ATE512978T1 - Bakterielle superantigenimpfstoffe - Google Patents

Bakterielle superantigenimpfstoffe

Info

Publication number
ATE512978T1
ATE512978T1 AT09001558T AT09001558T ATE512978T1 AT E512978 T1 ATE512978 T1 AT E512978T1 AT 09001558 T AT09001558 T AT 09001558T AT 09001558 T AT09001558 T AT 09001558T AT E512978 T1 ATE512978 T1 AT E512978T1
Authority
AT
Austria
Prior art keywords
superantigen
spea
altered
vaccines
attenuated
Prior art date
Application number
AT09001558T
Other languages
English (en)
Inventor
Robert G Ulrich
Original Assignee
U S Medical Res Inst Of Infectious Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U S Medical Res Inst Of Infectious Diseases filed Critical U S Medical Res Inst Of Infectious Diseases
Application granted granted Critical
Publication of ATE512978T1 publication Critical patent/ATE512978T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT09001558T 2001-11-26 2001-11-26 Bakterielle superantigenimpfstoffe ATE512978T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01996119A EP1461433A1 (de) 2001-11-26 2001-11-26 Bakterielle superantigen-impfstoffe
PCT/US2001/046540 WO2003056015A1 (en) 2001-11-26 2001-11-26 Bacterial superantigen vaccines

Publications (1)

Publication Number Publication Date
ATE512978T1 true ATE512978T1 (de) 2011-07-15

Family

ID=21743073

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09001558T ATE512978T1 (de) 2001-11-26 2001-11-26 Bakterielle superantigenimpfstoffe

Country Status (6)

Country Link
EP (2) EP2083016B1 (de)
AT (1) ATE512978T1 (de)
AU (1) AU2002227232A1 (de)
CA (1) CA2506538C (de)
DK (1) DK2083016T3 (de)
WO (1) WO2003056015A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
US11260120B2 (en) 2017-07-27 2022-03-01 Integrated Biotherapeutic Vaccines, Inc. Immunogenic composition comprising a fusion peptide derived from superantigen toxoids
EP4081534B1 (de) * 2020-12-18 2023-06-28 Biomedizinische Forschung & Bio-Produkte AG Impfstoff zum schutz gegen staphylokokken-exotoxin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6555494A (en) * 1993-04-05 1994-10-24 National Jewish Center For Immunology And Respiratory Medicine Method for treating kawasaki syndrome via immune modulation
AU4106596A (en) * 1994-11-14 1996-06-06 National Jewish Center For Immunology And Respiratory Medicine Protective effects of mutated superantigens
DE69737032D1 (de) * 1996-12-06 2007-01-11 Univ Minnesota Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
AU762813B2 (en) * 1998-08-13 2003-07-03 Walter Reed Army Institute Of Research Bacterial superantigen vaccines

Also Published As

Publication number Publication date
EP1461433A1 (de) 2004-09-29
DK2083016T3 (da) 2011-10-03
AU2002227232A1 (en) 2003-07-15
CA2506538C (en) 2013-07-09
WO2003056015A1 (en) 2003-07-10
CA2506538A1 (en) 2003-07-10
EP2083016A1 (de) 2009-07-29
EP2083016B1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
DE602004024542D1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
EP1545597A4 (de) Immunstimulatorische zusammensetzungen und verfahren zur stimulierung einer immunantwort
ATE426412T1 (de) Adjuvante influenza-vakzine
MY149604A (en) C.perfringens alpha toxoid vaccine
DK1354034T3 (da) Transgene transchromosomale gnavere til fremstilling af humane antistoffer
ATE449840T1 (de) Alpha-amylasevariante mit veränderten eigenschaften
HK1046016B (zh) 疫苗中的重組脫氧核糖核酸膠原
TR200704553T2 (tr) Streptokok antijenleri.
DE69713408D1 (de) Streptococcus equi Impstoff
ATE426026T1 (de) Chimare arterivirus-ahnliche partikel
ATE542829T1 (de) Impfstoff
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
WO2006123155A3 (en) Vaccine composition comprising b-subunit of e. coli heat toxin and an atigen and an adjuvant
MXPA02004627A (es) Vacunas contra el micoplasma bovis y sus metodos de uso.
DK1461054T3 (da) Gram-positive bakteriepræparater til behandling af sygdomme omfattende en immundysregulering
ATE375804T1 (de) Ribavirin-enthaltende vakzine
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
DE60136360D1 (de) Antigen aus streptococcus pyogenes
ATE512978T1 (de) Bakterielle superantigenimpfstoffe
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
WO2003097089A3 (de) Attenuierung von metapneumovirus
ATE484744T1 (de) Impfstoffe die gegen streptococcus pneumonia infektionen schützen.
ATE392209T1 (de) Apikomplex-vakzine-stämme einer familie von sarcocystidae
ATE392429T1 (de) Lebend-impfstoff gegen heliobacter pylori

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties